Will Eiger's Zokinvy Make History To Become First-ever Progeria Treatment?

Shares of Eiger BioPharmaceuticals Inc. (EIGR) are down 44 percent from their 52-week high of $15.82, recorded on December 26, 2019, and trade around $8.00.

from RTT - Biotech https://ift.tt/324W5sv
via IFTTT